Abstract
Background/Objectives
Bioimpedance analysis is often routinely performed in any dialysis unit to guide fluid management but can provide a reproduceable assessment of fat and muscle mass. We wished to determine the clinical significance of low muscle or high fat mass and the determinants that influence their change.
Subjects/Methods
We performed retrospective analysis of 824 patients on peritoneal dialysis who underwent routine repeated bioimpedance analysis measurements using the body composition monitor (BCM).
Results
Lean tissue index (LTI) was an independent predictor of mortality when sex, age, PD vintage and diabetes status were included in the models (HR 0.93; 95% CI 0.86–1.00, p < 0.05) and when baseline serum albumin was included in a separate model (HR 0.86; 95% CI: 0.79–0.93, p < 0.001). High fat tissue index (FTI) was an independent predictor of mortality when demographic factors were included (HR 0.87; 95% CI: 0.78–0.97, p < 0.02), but not with the addition biochemical parameters. Changes in body composition of 206 patients over a 2-year follow-up period could not be predicted by baseline demographics, functional or biochemical assessments. However, there was a strong inverse relationship between changes in LTI and FTI. There were no associations between changes in body composition with prescribed dialysate glucose.
Conclusions
We showed body composition changes are common and complex. LTI was an independent predictor of survival. Changes in LTI and FTI could not be predicted by baseline parameters. BCM may be a sensitive and accurate tool to monitor changes in body composition during dialysis treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23.
Baker JP, Detsky AS, Wesson DE, Wolman SL, Stewart S, Whitewell J, et al. Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med. 1982;306:969–72.
Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enter Nutr. 1987;11:8–13.
Tangvoraphonkchai K, Hung R, Sadeghi-Alavijeh O, Davenport A. Differences in prevalence of muscle weakness (sarcopenia) in haemodialysis patients determined by hand grip strength due to variation in guideline definitions of sarcopenia. Nutr Clin Pract. 2018;33:255–60.
Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos DG. Excessive weight gain during peritoneal dialysis. Int J Artif Organs. 2001;24:197–202.
Kim JK, Kim YS, Song YR, Kim HJ, Kim SG, Moon SJ. Excessive weight gain during the first year of peritoneal dialysis is associated with inflammation, diabetes mellitus, and a rapid decrease in residual renal function. PLoS ONE. 2015;10:e0139033.
Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793–808.
Vareldzis R, Naljayan M, Reisin E. The incidence and pathophysiology of the obesity paradox: should peritoneal dialysis and kidney transplant be offered to patients with obesity and end-stage renal disease? Curr Hypertens Rep. 2018;20:84.
Avram MM, Fein PA, Borawski C, Chattopadhyay J, Matza B. Extracellular mass/body cell mass ratio is an independent predictor of survival in peritoneal dialysis patients. Kidney Int Suppl. 2010;78(Suppl 117):S37–40.
Koh KH, Wong HS, Go KW, Morad Z. Normalized bioimpedance indices are better predictors of outcome in peritoneal dialysis patients. Perit Dial Int. 2011;31:574–82.
Molina P, Vizcaino B, Molina MD, Beltran S, Gonzalez-Moya M, Mora A, et al. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study. Nephrol Dial Transplant. 2018;33:1223–35.
Kittiskulnam P, Chertow GM, Carrero JJ, Delgado C, Kaysen GA, Johansen KL. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017;92:238–47.
Ahmadi SF, Zahmatkesh G, Streja E, Mehrotra R, Rhee CM, Kovesdy CP, et al. Association of body mass index with mortality in peritoneal dialysis patients: a systematic review and meta-analysis. Perit Dial Int. 2016;36:315–25.
Kiran VR, Zhu TY, Yip T, Lui SL, Lo WK. Body mass index and mortality risk in Asian peritoneal dialysis patients in Hong Kong-impact of diabetes and cardiovascular disease status. Perit Dial Int. 2014;34:390–8.
Liu J, Zeng X, Hong HG, Li Y, Fu P. The association between body mass index and mortality among Asian peritoneal dialysis patients: a meta-analysis. PLoS ONE. 2017;12:e0172369.
Choi SJ, Kim EJ, Park MY, Kim JK, Hwang SD. Does body fat mass define survival in patients starting peritoneal dialysis? Perit Dial Int. 2014;34:376–82.
Badve SV, Paul SK, Klein K, Clayton PA, Hawley CM, Brown FG, et al. The association between body mass index and mortality in incident dialysis patients. PLoS ONE. 2014;9:e114897.
Xiong L, Cao S, Xu F, Zhou Q, Fan L, Xu Q, et al. Association of body mass index and body mass index change with mortality in incident peritoneal dialysis patients. Nutrients. 2015;7:8444–55.
Fan S, Davenport A. Does increased glucose exposure lead to increased body fat and reduced lean body mass in anuric peritoneal dialysis patients? Eur J Clin Nutr. 2014;68:1253–4.
Caron-Lienert RS, Poli-de-Figueiredo CE, Figueiredo A, da Costa BEP, Crepaldi C, Pizzato AC, et al. The influence of glucose exposure load and peritoneal membrane transport on body composition and nutritional status changes after 1 year on peritoneal dialysis. Perit Dial Int. 2017;37:458–63.
Ho LC, Yen CJ, Chao CT, Chiang CK, Huang JW, Hung KY. Visceral fat area is associated with HbA1c but not dialysate-related glucose load in nondiabetic PD patients. Sci Rep. 2015;5:12811.
Bernardo AP, Oliveira JC, Santos O, Carvalho MJ, Cabrita A, Rodrigues A. Insulin resistance in nondiabetic peritoneal dialysis patients: associations with body composition, peritoneal transport, and peritoneal glucose absorption. Clin J Am Soc Nephrol. 2015;10:2205–12.
Lo WK. Metabolic syndrome and obesity in peritoneal dialysis. Kidney Res Clin Pract. 2016;35:10–4.
Obi Y, Streja E, Mehrotra R, Rivara MB, Rhee CM, Soohoo M, et al. Impact of obesity on modality longevity, residual kidney function, peritonitis, and survival among incident peritoneal dialysis patients. Am J Kidney Dis. 2018;71:802–13.
Davenport A. Does peritoneal dialysate affect body composition assessments using multi-frequency bioimpedance in peritoneal dialysis patients? Eur J Clin Nutr. 2013;67:223–5.
Paudel K, Visser A, Burke S, Samad N, Fan SL. Can bioimpedance measurements of lean and fat tissue mass replace subjective global assessments in peritoneal dialysis patients?. J Ren Nutr. 2015;25:480–7.
Omichi Y, Srivareerat M, Panorchan K, Greenhall GH, Gupta S, Davenport A. Measurement of muscle strength in haemodialysis patients by pinch and hand grip strength and comparison to lean body mass measured by multifrequency bio-electrical impedance. Ann Nutr Metab. 2016;68:268–75.
Yoowannakul S, Tangvoraphonkchai K, Davenport A. The prevalence of muscle wasting (sarcopenia) in peritoneal dialysis patients varies with ethnicity due to differences in muscle mass measured by bioimpedance. Eur J Clin Nutr. 2018;72:381–7.
Acknowledgements
This study was funded through local departmental funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Prior to 2014, SLF received lecture fees from Fresenius Medical Care.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Parthasarathy, R., Oei, E. & Fan, S.L. Clinical value of body composition monitor to evaluate lean and fat tissue mass in peritoneal dialysis. Eur J Clin Nutr 73, 1520–1528 (2019). https://doi.org/10.1038/s41430-019-0391-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-019-0391-3
This article is cited by
-
Bioimpedance analysis in children on peritoneal dialysis: to fill or not to fill?
Pediatric Nephrology (2024)
-
Associations among body composition parameters and quality of life in peritoneal dialysis patients
Scientific Reports (2022)
-
Association analysis of body composition with survival among prevalent peritoneal dialysis patients
International Urology and Nephrology (2022)
-
Muscle strength performed better than muscle mass in identifying cognitive impairment risk in maintenance hemodialysis patients
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2022)
-
The cut-off values of handgrip strength and lean mass index for sarcopenia among patients on peritoneal dialysis
Nutrition & Metabolism (2020)